A phase I study of VNP40101M [laromustine] and cytarabine for patients with hematologic malignancies.
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Laromustine (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia; Anaemia; Chronic myeloid leukaemia; Chronic myelomonocytic leukaemia; Haematological malignancies; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 13 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2005 New trial record.